Strategies to Target Drugs to Gliomas and CNS Metastases of Solid Tumors

Overview

Journal J Neurol

Specialty Neurology

Date 2015 Oct 19

PMID 26477024

Citations 3

Authors

B Milojkovic Kerklaan

O van Tellingen

A D R Huitema

J H Beijnen

W Boogerd

J H M Schellens

D Brandsma

Affiliations

Soon will be listed here.

Abstract

The treatment for central nervous system metastases of solid tumors and gliomas is limited as the blood-brain barrier (BBB) is an obstacle to systemic therapy. Here, we review the physiochemical properties of the BBB and both current and new drug strategies to penetrate brain tumors. We focus on targeting receptor- or carrier-mediated transport mechanisms over the BBB used by drug conjugates, nanoparticles, polymer-based nanocarriers, siRNA, and antibodies.

Citing Articles

Dual Chemotherapeutic Loading in Oxalate Transferrin-Conjugated Polymersomes Incorporated into Chitosan Hydrogels for Site-Specific Targeting of Melanoma Cells.

Aranha M, Alencar L, Souto E, Kamei D, Lopes A Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338339 PMC: 11434979. DOI: 10.3390/ph17091177.

Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context.

Saunus J, McCart Reed A, Lim Z, Lakhani S Int J Mol Sci. 2017; 18(1).

PMID: 28098771 PMC: 5297785. DOI: 10.3390/ijms18010152.

Concepts in glioma immunotherapy.

Platten M, Bunse L, Wick W, Bunse T Cancer Immunol Immunother. 2016; 65(10):1269-75.

PMID: 27460064 PMC: 11029493. DOI: 10.1007/s00262-016-1874-x.

References

Deane R, Zlokovic B . Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res. 2007; 4(2):191-7. DOI: 10.2174/156720507780362245. View

Dufes C, Al Robaian M, Somani S . Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells. Ther Deliv. 2013; 4(5):629-40. DOI: 10.4155/tde.13.21. View

Grover A, Hirani A, Pathak Y, Sutariya V . Brain-targeted delivery of docetaxel by glutathione-coated nanoparticles for brain cancer. AAPS PharmSciTech. 2014; 15(6):1562-8. PMC: 4245440. DOI: 10.1208/s12249-014-0165-0. View

Bondy M, Scheurer M, Malmer B, Barnholtz-Sloan J, Davis F, Ilyasova D . Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008; 113(7 Suppl):1953-68. PMC: 2861559. DOI: 10.1002/cncr.23741. View

Drappatz J, Brenner A, Wong E, Eichler A, Schiff D, Groves M . Phase I study of GRN1005 in recurrent malignant glioma. Clin Cancer Res. 2013; 19(6):1567-76. DOI: 10.1158/1078-0432.CCR-12-2481. View

Kannan R, Kuhlenkamp J, Jeandidier E, Trinh H, Ookhtens M, Kaplowitz N . Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat. J Clin Invest. 1990; 85(6):2009-13. PMC: 296671. DOI: 10.1172/JCI114666. View

Wick W, Puduvalli V, Chamberlain M, van den Bent M, Carpentier A, Cher L . Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma. J Clin Oncol. 2010; 28(7):1168-74. PMC: 2834468. DOI: 10.1200/JCO.2009.23.2595. View

Spuch C, Ortolano S, Navarro C . LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease. Front Physiol. 2012; 3:269. PMC: 3429044. DOI: 10.3389/fphys.2012.00269. View

Saunders N, Daneman R, Dziegielewska K, Liddelow S . Transporters of the blood-brain and blood-CSF interfaces in development and in the adult. Mol Aspects Med. 2013; 34(2-3):742-52. DOI: 10.1016/j.mam.2012.11.006. View

10.

Cairncross G, Wang M, Shaw E, Jenkins R, Brachman D, Buckner J . Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol. 2012; 31(3):337-43. PMC: 3732012. DOI: 10.1200/JCO.2012.43.2674. View

11.

Prados M, Schold Jr S, Fine H, Jaeckle K, Hochberg F, Mechtler L . A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. Neuro Oncol. 2003; 5(2):96-103. PMC: 1920676. DOI: 10.1093/neuonc/5.2.96. View

12.

Gazzin S, Strazielle N, Schmitt C, Fevre-Montange M, Ostrow J, Tiribelli C . Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces. J Comp Neurol. 2008; 510(5):497-507. DOI: 10.1002/cne.21808. View

13.

Kornguth S, Anderson M, Turski P, Sorenson J, Robins H, Cohen J . Glioblastoma multiforme: MR imaging at 1.5 and 9.4 T after injection of polylysine-DTPA-Gd in rats. AJNR Am J Neuroradiol. 1990; 11(2):313-8. PMC: 8334681. View

14.

Chamberlain M, Soffietti R, Raizer J, Ruda R, Brandsma D, Boogerd W . Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials. Neuro Oncol. 2014; 16(9):1176-85. PMC: 4136900. DOI: 10.1093/neuonc/nou089. View

15.

Birngruber T, Ghosh A, Perez-Yarza V, Kroath T, Ratzer M, Pieber T . Cerebral open flow microperfusion: a new in vivo technique for continuous measurement of substance transport across the intact blood-brain barrier. Clin Exp Pharmacol Physiol. 2013; 40(12):864-71. DOI: 10.1111/1440-1681.12174. View

16.

Batchelor T, Mulholland P, Neyns B, Nabors L, Campone M, Wick A . Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma. J Clin Oncol. 2013; 31(26):3212-8. PMC: 4021043. DOI: 10.1200/JCO.2012.47.2464. View

17.

Niu J, Wang A, Ke Z, Zheng Z . Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating. J Drug Target. 2014; 22(8):712-23. DOI: 10.3109/1061186X.2014.913052. View

18.

Gaillard P, Visser C, de Boer A . Targeted delivery across the blood-brain barrier. Expert Opin Drug Deliv. 2005; 2(2):299-309. DOI: 10.1517/17425247.2.2.299. View

19.

Zlokovic B . Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 2005; 28(4):202-8. DOI: 10.1016/j.tins.2005.02.001. View

20.

Zagzag D, Goldenberg M, Brem S . Angiogenesis and blood-brain barrier breakdown modulate CT contrast enhancement: an experimental study in a rabbit brain-tumor model. AJR Am J Roentgenol. 1989; 153(1):141-6. DOI: 10.2214/ajr.153.1.141. View